{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:35:46Z","timestamp":1774038946640,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,8,21]],"date-time":"2012-08-21T00:00:00Z","timestamp":1345507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s10120-012-0185-y","type":"journal-article","created":{"date-parts":[[2012,8,20]],"date-time":"2012-08-20T16:17:12Z","timestamp":1345479432000},"page":"329-337","source":"Crossref","is-referenced-by-count":22,"title":["Influence of Helicobacter pylori status and eradication on the serum levels of trefoil factors and pepsinogen test: serum trefoil factor 3 is a stable biomarker"],"prefix":"10.1007","volume":"16","author":[{"given":"Mitsuru","family":"Kaise","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Tagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasukazu","family":"Ohmoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,21]]},"reference":[{"key":"185_CR1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrm1203","volume":"4","author":"D Taupin","year":"2003","unstructured":"Taupin D, Podolsky DK. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol. 2003;4:721\u201332.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"185_CR2","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1053\/j.gastro.2010.08.043","volume":"139","author":"AJ Peterson","year":"2010","unstructured":"Peterson AJ, Menheniott TR, O\u2019Connor L, Walduck AK, Fox JG, Kawakami K, et al. Helicobacter pylori infection promotes methylation and silencing of trefoil factor 2, leading to gastric tumor development in mice and humans. Gastroenterology. 2010;139:2005\u201317.","journal-title":"Gastroenterology"},{"key":"185_CR3","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1158\/1078-0432.CCR-05-0671","volume":"11","author":"DK Dhar","year":"2005","unstructured":"Dhar DK, Wang TC, Tabara H, Tonomoto Y, Maruyama R, Tachibana M, et al. Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis. Clin Cancer Res. 2005;11:6472\u20138.","journal-title":"Clin Cancer Res"},{"key":"185_CR4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.tem.2007.10.003","volume":"19","author":"JK Perry","year":"2008","unstructured":"Perry JK, Kannan N, Grandison PM, Mitchell MD, Lobie PE. Are trefoil factors oncogenic? Trends Endocrinol Metab. 2008;19:74\u201381.","journal-title":"Trends Endocrinol Metab"},{"key":"185_CR5","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s00535-011-0396-8","volume":"46","author":"M Kaise","year":"2011","unstructured":"Kaise M, Miwa J, Tashiro J, Ohmoto Y, Morimoto S, Kato M, et al. The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer -a new marker for gastric cancer risk. J Gastroenterol. 2011;46:736\u201345.","journal-title":"J Gastroenterol"},{"key":"185_CR6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-1-4615-1871-6_17","volume":"362","author":"K Miki","year":"1995","unstructured":"Miki K, Ichinose M, Kakei N, Yahagi N, Matsushima M, Tsukada S, et al. The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer. Adv Exp Med Biol. 1995;362:139\u201343.","journal-title":"Adv Exp Med Biol"},{"key":"185_CR7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/gut.44.5.693","volume":"44","author":"F Kitahara","year":"1999","unstructured":"Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA, et al. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut. 1999;44:693\u20137.","journal-title":"Gut"},{"key":"185_CR8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1258\/0969141041732184","volume":"11","author":"M Dinis-Ribeiro","year":"2004","unstructured":"Dinis-Ribeiro M, Yamaki G, Miki K, Costa-Pereira A, Matsukawa M, Kurihara M. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen. 2004;11:141\u20137.","journal-title":"J Med Screen"},{"key":"185_CR9","doi-asserted-by":"crossref","unstructured":"Aikou S, Ohmoto Y, Gunji T, Matsuhashi N, Ohtsu H, Miura H, et al. Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening. Gastroenterology. 2011;141:837\u201345","DOI":"10.1053\/j.gastro.2011.05.040"},{"key":"185_CR10","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/sj.bjc.6604546","volume":"99","author":"E Bignotti","year":"2008","unstructured":"Bignotti E, Ravaggi A, Tassi RA, Calza S, Rossi E, Falchetti M, et al. Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas. Br J Cancer. 2008;99:768\u201373.","journal-title":"Br J Cancer"},{"key":"185_CR11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1158\/1078-0432.CCR-05-1545","volume":"12","author":"EM Vestergaard","year":"2006","unstructured":"Vestergaard EM, Borre M, Poulsen SS, Nex\u00f8 E, T\u00f8rring N. Plasma levels of trefoil factors are increased in patients with advanced prostate cancer. Clin Cancer Res. 2006;12:807\u201312.","journal-title":"Clin Cancer Res"},{"key":"185_CR12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10787-006-0009-y","volume":"15","author":"T Kawai","year":"2007","unstructured":"Kawai T, Miki K, Ichinose M, et al. Changes in evaluation of the pepsinogen test result following Helicobacter pylori eradication therapy in Japan. Inflammopharmacology. 2007;15:31\u20135.","journal-title":"Inflammopharmacology"},{"key":"185_CR13","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/path.1147","volume":"197","author":"WK Leung","year":"2002","unstructured":"Leung WK, Yu J, Chan FK, To KF, Chan MW, Ebert MP, et al. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues. J Pathol. 2002;197:582\u20138.","journal-title":"J Pathol"},{"key":"185_CR14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1369\/jhc.6A7100.2007","volume":"55","author":"J Madsen","year":"2007","unstructured":"Madsen J, Nielsen O, Tornoe I, Thim L, Holmskov U. Tissue localization of human trefoil factors 1, 2 and 3. J Histochem Cytochem. 2007;55:505\u201313.","journal-title":"J Histochem Cytochem"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-012-0185-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10120-012-0185-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-012-0185-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T10:19:08Z","timestamp":1559125148000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10120-012-0185-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,21]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["185"],"URL":"https:\/\/doi.org\/10.1007\/s10120-012-0185-y","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,21]]}}}